Fujian Wanchen Biotechnology Group: Legal opinion of Guohao Law Firm (Beijing) on the fourth interim shareholders' meeting of Fujian Wanchen Biological Technology Group Co., Ltd. in 2024.
Fujian Wanchen Biotechnology Group: Announcement of Resolutions of the Fourth Extraordinary Shareholders' Meeting in 2024.
Fujian Wanchen Biotechnology Group: Announcement of Resolution of the Fifteenth Meeting of the Fourth Supervisor Board.
Fujian Wanchen Biotechnology Group: Announcement of the resolutions of the 14th meeting of the 4th board of directors.
Fujian Wanchen Biotechnology Group: Opinions reviewed at the fifth special meeting of the board of directors of the fourth board of independent directors.
Fujian Wanchen Biotechnology Group: Notice of the company's fourth extraordinary shareholders' meeting in 2024.
Fujian Wanchen Biotechnology Group: Announcement Regarding the Provision of Financial Support to a Subsidiary under Control
Fujian Wanchen Biotechnology Group: Huaxing Securities Co., Ltd.'s Verification Opinion on Fujian Wanchen Biological Technology Group Co., Ltd.'s Provision of Financial Assistance to its Subsidiary.
Fujian Wanchen Biotechnology Group: Information disclosure management system of Fujian Wanchen Biological Technology Group Co., Ltd.
Fujian Wanchen Biotechnology Group: Announcement on the cancellation of pledge of partial shares by the actual controller
Fujian Wanchen Biotechnology Group: Announcement on the attribution of the first vesting period of the 2023 restricted stock incentive plan and the listing of stocks
Fujian Wanchen Biotechnology Group: Investor Relations Activity Record Form of Fujian Wanchen Biotechnology Group Co., Ltd.
Fujian Wanchen Biotechnology Group: Legal Opinion of Attorney Guo Hao (Beijing) Office on the Achievement of the Ownership Conditions and Cancellation of Some Restricted Shares during the First Vesting Period of the 2023 Restricted Stock Incentive Plan of Fujian Wanchen Biotechnology Group Co., Ltd.
Fujian Wanchen Biotechnology Group: Independent Financial Advisory Report of Shanghai Xingong Yihe Enterprise Management Consulting Co., Ltd. on matters relating to the ownership of the first vesting period of the 2023 Restricted Stock Incentive Plan of Fujian Wanchen Biotechnology Group Co., Ltd.
Fujian Wanchen Biotechnology Group: Announcement on abolishing part of the 2023 Restricted Stock Incentive Plan and granting restricted stocks that have not yet been vested
Fujian Wanchen Biotechnology Group: Announcement on the achievement of the ownership conditions during the first vesting period of the company's 2023 Restricted Stock Incentive Plan
Fujian Wanchen Biotechnology Group: Announcement of Resolutions of the 14th Meeting of the Fourth Board of Supervisors
Fujian Wanchen Biotechnology Group: The Supervisory Board's opinion on the verification list for the first vesting period of the company's 2023 Restricted Stock Incentive Plan
Fujian Wanchen Biotechnology Group: Announcement of Resolutions of the 13th Meeting of the Fourth Board of Directors
Fujian Wanchen Biotechnology Group: Announcement on the actual controller's partial share pledge
No Data